Chronic Illness and Expensive Medical Treatment in Morocco: How ALD and ALC Coverage Works under CNSS

A detailed guide to long-term illness recognition, medical expense exemptions, cancer treatment, diabetes, dialysis, psychiatric disorders, rare diseases, costly medicines, reimbursement rates, applications, renewals and appeals.

Living with a chronic illness often means dealing with two separate burdens. The first is medical: appointments, prescriptions, monitoring, complications and treatments that may continue for years. The second is financial and administrative: finding out what health insurance will cover, obtaining authorization and ensuring that treatment remains affordable.

In Morocco, a person with diabetes may continue paying for medication every month without knowing that the condition appears on the regulatory list of serious long-term illnesses.

A family facing a cancer diagnosis may struggle to arrange an expensive treatment before understanding the insurer's special coverage procedures. A patient with a serious psychiatric condition may have ongoing medical expenses without having applied for recognition under the relevant long-term illness category.

Morocco's compulsory health insurance legislation provides special arrangements for certain chronic, disabling or particularly costly conditions.

These are commonly described using the French abbreviations ALD and ALC.

Recognition can change the financial rules governing eligible treatment. It does not, however, mean that every medical bill will automatically be paid in full.

This guide explains who may qualify, what recognition means, how to prepare a medical file and what patients and families should check before committing to expensive care.

1. What does ALD mean in Morocco?

ALD stands for Affection de Longue Durée, generally described in English as a long-term medical condition or long-term illness.

The classification covers specified serious or disabling diseases that require prolonged medical treatment. Some conditions are lifelong. Others demand extended monitoring or intensive treatment over a substantial period.

Examples include diabetes, certain cardiovascular disorders, multiple sclerosis, severe neurological illnesses and some serious psychiatric conditions.

A long-term illness can create substantial financial pressure even when individual prescriptions are relatively inexpensive.

Medication, medical appointments, diagnostic testing, rehabilitation and hospitalization may accumulate into a large cost over time.

Does every chronic disease qualify?

No.

Moroccan regulations establish recognized categories of serious or disabling illnesses. Some categories also contain clinical severity requirements.

For example, severe asthma and severe arterial hypertension appear in the official list. This does not establish that every person with asthma or hypertension automatically qualifies for the relevant special coverage.

The precise diagnosis, severity and supporting medical evidence matter.

2. What does ALC mean?

ALC stands for Affection Lourde et Coûteuse, referring to a serious or particularly costly medical condition.

The category addresses treatment that can generate exceptionally high expenses. Examples include certain organ transplants, major cardiovascular interventions and other specialized treatment.

Ministerial Order No. 2518-05 identifies particularly costly treatment associated with kidney, liver, heart, corneal or other ocular tissue, and bone marrow transplantation, together with specified cardiovascular conditions.

A patient may have an illness that is both long-term and particularly expensive.

Someone receiving regular dialysis, for example, may require continuing treatment and potentially undergo a kidney transplant.

The relevant reimbursement conditions must be examined for each phase of care.

3. Which laws regulate ALD and ALC coverage?

The principal legal framework is Law No. 65-00, Morocco's Basic Medical Coverage Code.

Decree No. 2-05-733 establishes important provisions concerning medical coverage, prior authorization, medical review and exemptions from the insured person's normal contribution.

Ministerial Order No. 2518-05 of 5 September 2005 establishes the regulatory list of recognized serious or disabling illnesses requiring prolonged or particularly expensive care.

Separate regulations determine the rates of coverage, reimbursable medicines, approved devices and applicable reference tariffs.

These instruments must be considered together.

Being diagnosed with a condition appearing on the regulatory list is an important first step, but entitlement to a particular exemption or treatment authorization depends on the rules governing that decision.

4. The 41 officially listed long-term and serious illness categories

The annex to Ministerial Order No. 2518-05 contains 41 disease categories.

The following English names are intended to make the official classification understandable to patients while retaining the underlying medical distinctions.

Read Ministerial Order No. 2518-05 and its annex in the Official Bulletin (in French).

Several categories contain multiple diagnoses. Patients should therefore confirm the classification used for their exact condition rather than relying solely on the broad heading.

5. Does ALD recognition mean 100% reimbursement?

Not automatically.

For ordinary CNSS-covered care, the general reimbursement rate is 70% of the applicable National Reference Tariff.

Special arrangements for recognized serious long-term or costly diseases can increase coverage and reduce or eliminate the normal patient contribution for qualifying care. The applicable rate can differ by disease and treatment.

A particular recognition decision must therefore be examined before assuming that every service will receive the same percentage.

Example: treatment with a reference value of MAD 1,000

At 70%, reimbursement is MAD 700.

At 90%, reimbursement would be MAD 900.

At 100%, reimbursement would equal MAD 1,000.

These amounts explain the calculation. They do not establish that a particular disease automatically qualifies for one of those rates.

Why might a patient still pay after receiving a 100% exemption?

Suppose a healthcare provider charges MAD 1,800 for treatment with a recognized reference value of MAD 1,000.

If the applicable exemption allows 100% reimbursement of that reference value, the insurance payment may be MAD 1,000.

A difference of MAD 800 may remain, depending on the legally applicable provider agreement and billing rules.

It is essential to distinguish an exemption from the normal patient share of the reference tariff from full coverage of every actual expense.

6. How to apply for ALD recognition through CNSS

The procedure begins with a medical file establishing the condition and demonstrating how it corresponds to the regulatory classification.

CNSS has used a dedicated long-term illness assessment form identified as 610-1-01.

Patients should obtain the current official form before applying.

Consult the doctor responsible for your treatment

The treating physician should establish the diagnosis and identify the medical evidence required. Depending on the condition, the relevant specialist may be an endocrinologist, oncologist, nephrologist, cardiologist, neurologist, rheumatologist or psychiatrist.

Prepare the medical documentation

The file may include a detailed medical report, laboratory results, diagnostic imaging, hospital discharge summaries and specialist findings.

The exact requirements vary by illness.

A diabetes file is not documented in the same way as a lymphoma, neurological disorder or severe psychiatric condition.

Submit confidential medical information appropriately

Applications may involve sensitive medical documents intended for medical review. These should be sent through the appropriate confidential channels.

The insurer needs sufficient information to assess the request, but medical details should not be disclosed indiscriminately.

File the application and keep evidence

Submit the completed file through the accepted channel.

Retain copies and proof of submission.

If the patient is a dependant, ensure that the principal insured person's information and the patient's identity are correctly recorded.

Obtain the decision

Medical control may review the documents or request further information. The decision should allow the patient to establish the recognized condition, exemption terms and relevant validity or renewal requirements.

7. Must the medical report come from a specialist?

Requirements depend on the illness.

A general practitioner may manage some stable chronic conditions, but certain diagnoses need specialized evidence.

Cancer may require pathology findings.

Multiple sclerosis may require neurological evaluation and relevant imaging. Serious psychiatric conditions may require detailed assessment by a psychiatrist.

Before paying for additional tests solely for the application, ask which supporting documents are actually required.

8. How long does an ALD exemption remain valid?

The illness itself may be permanent, but the authorization is an administrative decision.

Article 10 of Decree No. 2-05-733 provides for exemptions to be granted following examination and medical review for renewable six-month periods under the stated conditions.

Patients should distinguish three separate matters: recognition of the underlying condition, validity of the exemption decision and authorization for a particular expensive treatment.

They may not all have the same duration.

How can you avoid an interruption?

Check expiry dates well in advance.

Ask which medical reports or updated investigations are necessary for renewal.

For essential medicines, do not wait until the last supply has been used before investigating an expiring authorization.

9. Can expenses incurred before ALD approval receive the higher rate?

A patient may need treatment before the recognition process is completed.

Whether earlier expenses can benefit from a later decision depends on the effective date of recognition, ordinary claim deadlines and the applicable rules.

Approval does not automatically reopen every historical medical expense.

For substantial costs, ask the insurer for a written determination concerning the period in question.

10. Diabetes: what does recognition change?

Diabetes appears explicitly in the regulatory list, including insulin-dependent and non-insulin-dependent forms.

The patient's medical needs may include prescriptions, blood glucose monitoring, kidney tests, eye examinations and cardiovascular assessment.

Some patients develop complications requiring substantial additional treatment.

Is insulin free after ALD recognition?

Not necessarily in every pharmacy or for every formulation.

Coverage depends on the medicine, reimbursement basis, applicable rate and any specific dispensing or public healthcare arrangement.

State-provided medicines through public healthcare programmes should also be distinguished from insurance reimbursement through private pharmacies.

What about glucose meters and continuous monitoring sensors?

Devices are subject to different reimbursement rules from medicines.

Check whether the specific device, test strips or sensor is approved and whether any renewal or authorization conditions apply.

What if diabetes causes kidney or eye disease?

The patient should ask the treating physician whether documented complications require the medical file to be updated.

Diabetic retinopathy and certain serious kidney conditions appear among the recognized disease categories.

11. Severe hypertension and cardiovascular disease

The regulatory list refers specifically to severe arterial hypertension.

Having high blood pressure or using antihypertensive medication does not automatically establish eligibility for the severe category.

Medical severity and documented complications may be decisive.

A patient who subsequently experiences heart failure, a major vascular event or a stroke should have their clinical situation reassessed.

New diagnoses may be relevant to the classification and financial treatment of subsequent care.

12. Cancer treatment and CNSS: organizing coverage after diagnosis

Cancer treatment can involve surgery, chemotherapy, radiotherapy, specialized medicines, diagnostic testing and repeated hospitalization.

The official list includes malignant tumours and malignant diseases involving blood-forming and lymphatic tissues.

What should the family do first?

Obtain a clear specialist report establishing the diagnosis and the proposed treatment plan.

Where relevant, pathology results and staging investigations may be important.

The family should investigate ALD recognition and any authorization requirements for planned therapy.

Are all cancer medicines automatically covered?

No.

Even where the disease itself is recognized, particular products or protocols may have separate reimbursement and authorization requirements.

Some expensive drugs may not be reimbursable under the ordinary list or may be restricted to specified medical indications.

What if the requested treatment is refused?

Ask whether the refusal concerns the medicine's reimbursable status, incomplete documentation, missing prior authorization or medical assessment.

The treating oncologist may provide additional evidence explaining the treatment's necessity.

Exceptional coverage procedures may be available under defined circumstances, but acceptance cannot be guaranteed.

13. Dialysis, kidney failure and transplantation

End-stage chronic renal failure is a recognized category.

Patients may require dialysis several times a week, with associated blood tests, specialist appointments, medication and hospitalization.

The cumulative expense can be considerable.

Can dialysis be arranged without paying the full cost first?

Direct-payment arrangements may be available under the applicable scheme and provider agreements.

The patient should verify the dialysis centre's arrangements, the authorization's validity and any additional charges.

For recurring treatment, continuity is especially important.

Is kidney transplantation covered?

Conditions requiring organ transplantation are included among the particularly costly situations addressed by the regulations.

Coverage of the operation, preoperative investigations and post-transplant medication must be checked individually.

Receiving a transplant does not necessarily remove the need for expensive ongoing treatment.

14. Psychiatric disorders: which conditions appear on the ALD list?

Morocco's official long-term illness classification includes several mental health categories.

These include psychotic disorders, severe personality disorders, and mental or personality disorders associated with brain dysfunction, physical disease or injury.

The list also contains a category concerning intellectual impairment.

These headings have a specific regulatory purpose. They should not be treated as interchangeable clinical diagnoses.

Is schizophrenia eligible?

Schizophrenia falls within the clinical group of psychotic disorders.

It may therefore qualify under the relevant regulatory category when the required diagnosis and assessment conditions are satisfied.

A psychiatrist should document the diagnosis and treatment needs.

What about bipolar disorder?

Bipolar disorder covers different clinical presentations.

Some patients experience psychotic features, but it would be inaccurate to assert that every bipolar diagnosis automatically qualifies under the psychosis category.

The exact diagnostic classification and applicable medical requirements must be examined.

Does depression qualify?

Depression can be severe and persistent, and some patients require intensive treatment.

Nevertheless, it should not be assumed that every depressive disorder qualifies for special long-term illness coverage.

The applicable Moroccan classification and decision must be checked.

Rules used in France should not automatically be substituted for Morocco's own ALD framework.

Are psychiatric medicines reimbursed at higher rates?

The patient's recognized diagnosis may affect the applicable coverage.

However, each medicine must also satisfy the relevant reimbursement and authorization requirements.

Antidepressants, antipsychotics and mood stabilizers do not all necessarily have identical coverage.

Does psychiatric ALD cover private psychotherapy?

Recognition of a severe psychiatric illness does not automatically make every private psychologist appointment reimbursable.

The professional's status, classification of the service and applicable benefit rules still matter.

Supplementary insurance may have different provisions.

Is psychiatric information confidential?

Psychiatric diagnoses and medical reports are sensitive health information.

Documents required for medical review should be handled through the proper confidential process.

An employer's duty to contribute to AMO does not grant unrestricted access to an employee's psychiatric file.

15. Multiple sclerosis, Parkinson's disease and other neurological conditions

The recognized categories include multiple sclerosis, Parkinson's disease and severe neurological or neuromuscular disorders.

Treatment may involve specialist consultations, imaging, long-term medicines, rehabilitation and medical devices.

Example: a patient with multiple sclerosis

A neurologist prescribes ongoing disease-modifying treatment and regular MRI monitoring.

ALD recognition can be important, but authorization for the medicine, reimbursement of the scans and eligibility for rehabilitation may each require separate checks.

16. Rheumatoid arthritis and autoimmune diseases

The official list includes severe progressive rheumatoid arthritis, systemic lupus erythematosus, vasculitis and other serious inflammatory conditions.

Some patients require costly biological therapies.

The severity threshold and the exact approved treatment are central to coverage decisions.

A diagnosis without evidence of the required clinical characteristics may not be sufficient for a particular exemption.

17. Rare diseases and exceptional coverage

Rare diseases can lead to substantial treatment costs even where the diagnosis does not clearly match a named category in the ordinary list.

Article 9 of Decree No. 2-05-733 provides a framework for exceptional coverage of certain rare chronic or costly illnesses, subject to the statutory procedure.

How can a family prepare the request?

Obtain a specialist report explaining the diagnosis, severity, recommended treatment and why it is medically necessary.

Include supporting investigations and a treatment cost estimate.

Ask the insurer whether the case can be examined under the applicable exceptional procedure.

This is an application mechanism, not a guarantee of financial approval.

18. How expensive can chronic medication become?

Example: monthly medication costing MAD 4,000

Assume the recognized reimbursement basis is MAD 3,000.

At 70%, reimbursement would be MAD 2,100, leaving MAD 1,900 per month.

If a hypothetical qualifying decision applied a rate of 95% to the same basis, reimbursement would be MAD 2,850, leaving MAD 1,150.

Over a full year, the difference between those scenarios would be MAD 9,000.

The 95% rate is used here only to demonstrate the arithmetic, not to assign that rate to any particular illness or medicine.

This is why patients should obtain the exact terms of their own decision.

19. Reimbursement versus direct coverage for expensive treatment

A high reimbursement percentage may still leave families struggling if they must advance the full expense.

Where direct-payment arrangements exist, the insurer can pay the covered amount directly to the provider.

Availability depends on the treatment, institution, authorizations and agreements.

An ALD decision does not automatically mean that every pharmacy or clinic must provide treatment without advance payment.

20. Hospitalization for ALD or ALC

A patient with a recognized serious condition may need inpatient treatment.

Planned hospitalization can require a separate authorization even where the illness has already been recognized.

The hospital should provide the medical justification and information needed for the application.

Treatment in public facilities

ACAPS states that CNSS coverage rises to 90% of the reference tariff for medically necessary treatment associated with qualifying serious, disabling, long-term or particularly costly illnesses when delivered by the specified public healthcare facilities.

AMO Tadamon has distinct arrangements for the portion of public healthcare costs normally left to the beneficiary.

What about private hospitals?

The coverage rate, reference tariff and provider agreement must be checked.

A special ALD exemption does not establish that an entire private hospital invoice will be covered.

21. Are all follow-up tests covered at the higher ALD rate?

An ALD patient may need regular laboratory examinations, scans and specialist appointments.

Whether a particular test benefits from the condition's special reimbursement rules depends on its medical relationship to the recognized illness and the applicable benefit provisions.

A person with diabetes may receive follow-up care for diabetic complications and also seek treatment for an unrelated condition.

Those services may be subject to different coverage rules.

Accurate documentation of the reason for treatment helps prevent administrative confusion.

22. Can someone have several recognized long-term illnesses?

Yes, a patient can have multiple chronic conditions.

Diabetes, heart disease and kidney failure may coexist.

A psychiatric condition may also occur alongside a separate physical illness.

Recognition of one condition does not automatically establish higher reimbursement for every other diagnosis.

A new condition may require an updated medical assessment or additional recognition process.

23. What happens if a patient loses their job?

ALD recognition concerns the medical condition and its special coverage provisions.

Insurance eligibility also depends on the person's continuing entitlement under an AMO scheme.

Losing employment can therefore create a separate administrative issue.

An affected patient should verify any temporary continuation of coverage and arrange transition to another scheme when necessary.

Patients receiving dialysis, chemotherapy or essential long-term medication should plan this transition before existing rights expire.

24. What about AMO Tadamon beneficiaries with chronic illness?

Under AMO Tadamon, eligible beneficiaries have their contributions funded by the state.

Special arrangements also apply to the patient's normal share of eligible treatment in public facilities.

The situation may be different in private facilities.

Patients should ask the relevant public healthcare provider about available services and check the financial conditions before choosing private care.

25. Can supplementary insurance pay the remaining amount?

A supplementary policy may cover part of the expense remaining after compulsory insurance reimbursement.

The amount depends on the contract, its limits and exclusions.

Patients with serious pre-existing conditions should examine terms relating to long-term medication, hospital benefits, annual caps and waiting periods.

A supplementary policy advertising 100% coverage may refer to a tariff basis rather than every fee charged.

26. What if CNSS refuses ALD recognition?

First determine whether the refusal is administrative or medical.

The insurer may consider the documentation incomplete, the regulatory classification inapplicable or the required severity criteria unmet.

Request a clear explanation.

Ask the treating physician to review the medical evidence.

Where the disagreement arises from medical assessment, use the legally applicable medical review procedure.

Keep the refusal decision, medical reports and submission records.

27. My ALD was approved, but I still receive ordinary reimbursements

Possible explanations include an earlier treatment date, an expired authorization, a service unrelated to the recognized disease or an incorrectly applied reimbursement category.

Review the recognition decision, dates, reference tariff and treatment classification.

A complaint identifying the exact discrepancy is more useful than a general statement that the reimbursement seems too low.

28. What if a doctor changes the treatment?

A chronic illness treatment plan can evolve.

A new drug, dose or treatment protocol may require updated medical documents or authorization.

Before purchasing particularly expensive medication, ask whether the existing approval covers the change.

The medical decision itself should remain with the treating professional.

29. Does ALD recognition entitle someone to a disability pension?

No automatic connection should be assumed.

ALD recognition primarily concerns medical coverage.

Sickness cash benefits, work incapacity compensation and invalidity pensions have their own conditions and assessment procedures.

A person may have a recognized chronic illness while remaining able to work.

Similarly, a decision about medical expense exemptions is not the same as a determination of occupational incapacity.

30. Frequently asked questions

My father has had diabetes for ten years. Can he still apply? The age of the diagnosis does not, by itself, prevent submission of an application. The current medical and administrative conditions must be met.

Can previous years of medicine bills be reimbursed after approval? Not automatically. Effective dates and ordinary claim deadlines still matter.

Does Alzheimer's disease qualify? The diagnosis must be examined against applicable neurological and brain-related categories; recognition should not be assumed without assessment.

Does autism automatically qualify? Autism is not expressly named among the 41 main categories in the 2005 annex. Any relevant associated diagnoses or alternative entitlements should be evaluated individually. Autism should not automatically be classified as psychosis or intellectual disability.

Can coverage continue after a disease becomes stable? Clinical stability does not necessarily mean the underlying condition has disappeared. Administrative validity and renewal requirements still apply.

Are transport costs to dialysis automatically covered? ALD status does not automatically establish a general entitlement to reimbursement of every journey.

Can a relative apply on behalf of a seriously ill patient? Representation may be possible under the applicable authorization and confidentiality rules.

Can treatment abroad be covered? Only under the relevant conditions, which may include prior approval for planned specialist treatment.

Conclusion: recognition is the beginning of a more manageable care pathway

Morocco's ALD and ALC arrangements can substantially reduce the financial pressure associated with serious illness.

Their practical value depends on obtaining the appropriate recognition, understanding the applicable reimbursement rate and keeping treatment authorizations valid.

Patients and families should know which services are covered, what reference tariffs apply, whether direct payment is available and when renewals are required.

For conditions requiring uninterrupted treatment, administrative continuity is especially important.

If recognition is refused or coverage is interrupted, the patient may need to use the complaint and appeal procedures available under Moroccan law.